Adeno-associated Virus Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512248883

Publication Date:

December 9, 2024

Pages:

117

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Adeno-Associated Virus (AAV) Packaging Service refers to a specialized service that provides the packaging of genetic material into AAV vectors. AAVs are commonly used in gene therapy and gene delivery applications due to their ability to efficiently deliver genetic material to target cells. However, AAV vectors need to be packaged with the desired genetic cargo before they can be used for research or therapeutic purposes. The AAV packaging service allows researchers and pharmaceutical companies to obtain high-quality AAV vectors without the need for extensive expertise or infrastructure for vector production. It enables efficient and reliable delivery of genetic material, facilitating various applications in gene therapy, gene editing, and gene expression regulation.
The global market for Adeno-associated Virus Packaging Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Adeno-associated Virus Packaging Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adeno-associated Virus Packaging Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Adeno-associated Virus Packaging Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Adeno-associated Virus Packaging Service include Applied Biological Materials (abm), VectorBuilder, Takara Bio, OriGene, Charles River, Cayman Chemical Company, PackGene, Cell Biolabs and WZ Biosciences, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adeno-associated Virus Packaging Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Adeno-associated Virus Packaging Service by region & country, by Type, and by Application.
The Adeno-associated Virus Packaging Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-associated Virus Packaging Service.
Market Segmentation
By Company
Applied Biological Materials (abm)
VectorBuilder
Takara Bio
OriGene
Charles River
Cayman Chemical Company
PackGene
Cell Biolabs
WZ Biosciences
药明康德
Segment by Type:
Small-scale
Medium-scale
Large-scale
Segment by Application
Gene Therapy
Cell Therapy
Drug Research & Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Adeno-associated Virus Packaging Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Adeno-associated Virus Packaging Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Adeno-associated Virus Packaging Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Adeno-associated Virus Packaging Service Product Introduction
1.2 Global Adeno-associated Virus Packaging Service Market Size Forecast
1.3 Adeno-associated Virus Packaging Service Market Trends & Drivers
1.3.1 Adeno-associated Virus Packaging Service Industry Trends
1.3.2 Adeno-associated Virus Packaging Service Market Drivers & Opportunity
1.3.3 Adeno-associated Virus Packaging Service Market Challenges
1.3.4 Adeno-associated Virus Packaging Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Adeno-associated Virus Packaging Service Players Revenue Ranking (2023)
2.2 Global Adeno-associated Virus Packaging Service Revenue by Company (2019-2024)
2.3 Key Companies Adeno-associated Virus Packaging Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Adeno-associated Virus Packaging Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Adeno-associated Virus Packaging Service
2.6 Adeno-associated Virus Packaging Service Market Competitive Analysis
2.6.1 Adeno-associated Virus Packaging Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Adeno-associated Virus Packaging Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-associated Virus Packaging Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Small-scale
3.1.2 Medium-scale
3.1.3 Large-scale
3.2 Global Adeno-associated Virus Packaging Service Sales Value by Type
3.2.1 Global Adeno-associated Virus Packaging Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Adeno-associated Virus Packaging Service Sales Value, by Type (2019-2030)
3.2.3 Global Adeno-associated Virus Packaging Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Therapy
4.1.2 Cell Therapy
4.1.3 Drug Research & Development
4.1.4 Others
4.2 Global Adeno-associated Virus Packaging Service Sales Value by Application
4.2.1 Global Adeno-associated Virus Packaging Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Adeno-associated Virus Packaging Service Sales Value, by Application (2019-2030)
4.2.3 Global Adeno-associated Virus Packaging Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Adeno-associated Virus Packaging Service Sales Value by Region
5.1.1 Global Adeno-associated Virus Packaging Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Adeno-associated Virus Packaging Service Sales Value by Region (2019-2024)
5.1.3 Global Adeno-associated Virus Packaging Service Sales Value by Region (2025-2030)
5.1.4 Global Adeno-associated Virus Packaging Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Adeno-associated Virus Packaging Service Sales Value, 2019-2030
5.2.2 North America Adeno-associated Virus Packaging Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Adeno-associated Virus Packaging Service Sales Value, 2019-2030
5.3.2 Europe Adeno-associated Virus Packaging Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Adeno-associated Virus Packaging Service Sales Value, 2019-2030
5.4.2 Asia Pacific Adeno-associated Virus Packaging Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Adeno-associated Virus Packaging Service Sales Value, 2019-2030
5.5.2 South America Adeno-associated Virus Packaging Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Adeno-associated Virus Packaging Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Adeno-associated Virus Packaging Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Adeno-associated Virus Packaging Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Adeno-associated Virus Packaging Service Sales Value
6.3 United States
6.3.1 United States Adeno-associated Virus Packaging Service Sales Value, 2019-2030
6.3.2 United States Adeno-associated Virus Packaging Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Adeno-associated Virus Packaging Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Adeno-associated Virus Packaging Service Sales Value, 2019-2030
6.4.2 Europe Adeno-associated Virus Packaging Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Adeno-associated Virus Packaging Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Adeno-associated Virus Packaging Service Sales Value, 2019-2030
6.5.2 China Adeno-associated Virus Packaging Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Adeno-associated Virus Packaging Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Adeno-associated Virus Packaging Service Sales Value, 2019-2030
6.6.2 Japan Adeno-associated Virus Packaging Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Adeno-associated Virus Packaging Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Adeno-associated Virus Packaging Service Sales Value, 2019-2030
6.7.2 South Korea Adeno-associated Virus Packaging Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Adeno-associated Virus Packaging Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Adeno-associated Virus Packaging Service Sales Value, 2019-2030
6.8.2 Southeast Asia Adeno-associated Virus Packaging Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Adeno-associated Virus Packaging Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Adeno-associated Virus Packaging Service Sales Value, 2019-2030
6.9.2 India Adeno-associated Virus Packaging Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Adeno-associated Virus Packaging Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Applied Biological Materials (abm)
7.1.1 Applied Biological Materials (abm) Profile
7.1.2 Applied Biological Materials (abm) Main Business
7.1.3 Applied Biological Materials (abm) Adeno-associated Virus Packaging Service Products, Services and Solutions
7.1.4 Applied Biological Materials (abm) Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.1.5 Applied Biological Materials (abm) Recent Developments
7.2 VectorBuilder
7.2.1 VectorBuilder Profile
7.2.2 VectorBuilder Main Business
7.2.3 VectorBuilder Adeno-associated Virus Packaging Service Products, Services and Solutions
7.2.4 VectorBuilder Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.2.5 VectorBuilder Recent Developments
7.3 Takara Bio
7.3.1 Takara Bio Profile
7.3.2 Takara Bio Main Business
7.3.3 Takara Bio Adeno-associated Virus Packaging Service Products, Services and Solutions
7.3.4 Takara Bio Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.3.5 OriGene Recent Developments
7.4 OriGene
7.4.1 OriGene Profile
7.4.2 OriGene Main Business
7.4.3 OriGene Adeno-associated Virus Packaging Service Products, Services and Solutions
7.4.4 OriGene Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.4.5 OriGene Recent Developments
7.5 Charles River
7.5.1 Charles River Profile
7.5.2 Charles River Main Business
7.5.3 Charles River Adeno-associated Virus Packaging Service Products, Services and Solutions
7.5.4 Charles River Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.5.5 Charles River Recent Developments
7.6 Cayman Chemical Company
7.6.1 Cayman Chemical Company Profile
7.6.2 Cayman Chemical Company Main Business
7.6.3 Cayman Chemical Company Adeno-associated Virus Packaging Service Products, Services and Solutions
7.6.4 Cayman Chemical Company Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.6.5 Cayman Chemical Company Recent Developments
7.7 PackGene
7.7.1 PackGene Profile
7.7.2 PackGene Main Business
7.7.3 PackGene Adeno-associated Virus Packaging Service Products, Services and Solutions
7.7.4 PackGene Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.7.5 PackGene Recent Developments
7.8 Cell Biolabs
7.8.1 Cell Biolabs Profile
7.8.2 Cell Biolabs Main Business
7.8.3 Cell Biolabs Adeno-associated Virus Packaging Service Products, Services and Solutions
7.8.4 Cell Biolabs Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.8.5 Cell Biolabs Recent Developments
7.9 WZ Biosciences
7.9.1 WZ Biosciences Profile
7.9.2 WZ Biosciences Main Business
7.9.3 WZ Biosciences Adeno-associated Virus Packaging Service Products, Services and Solutions
7.9.4 WZ Biosciences Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.9.5 WZ Biosciences Recent Developments
7.10 药明康德
7.10.1 药明康德 Profile
7.10.2 药明康德 Main Business
7.10.3 药明康德 Adeno-associated Virus Packaging Service Products, Services and Solutions
7.10.4 药明康德 Adeno-associated Virus Packaging Service Revenue (US$ Million) & (2019-2024)
7.10.5 药明康德 Recent Developments
8 Industry Chain Analysis
8.1 Adeno-associated Virus Packaging Service Industrial Chain
8.2 Adeno-associated Virus Packaging Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Adeno-associated Virus Packaging Service Sales Model
8.5.2 Sales Channel
8.5.3 Adeno-associated Virus Packaging Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Applied Biological Materials (abm)
VectorBuilder
Takara Bio
OriGene
Charles River
Cayman Chemical Company
PackGene
Cell Biolabs
WZ Biosciences
药明康德

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂